Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Holding XLO?
Track your performance easily

Xilio Therapeutics (XLO) Financial Statements

100 Followers

Xilio Therapeutics Financial Overview

Xilio Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.57; its P/E ratio is -0.40; Xilio Therapeutics is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -17.20M$ -17.65M$ -16.75M$ -19.36M$ -22.65M
EBITDA$ -16.76M$ -17.20M$ -16.29M$ -18.86M$ -22.15M
Net Income Common Stockholders$ -17.20M$ -17.65M$ -16.75M$ -19.36M$ -22.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 34.00M$ 44.70M$ 59.80M$ 75.40M$ 93.30M
Total Assets$ 82.61M$ 60.93M$ 77.84M$ 92.38M$ 111.50M
Total Debt$ 8.94M$ 12.50M$ 14.39M$ 16.81M$ 18.11M
Net Debt$ -25.06M$ -32.20M$ -45.41M$ -58.59M$ -75.19M
Total Liabilities$ 56.84M$ 24.10M$ 25.34M$ 24.98M$ 26.71M
Stockholders Equity$ 25.77M$ 36.83M$ 52.50M$ 67.39M$ 84.79M
Cash Flow-
Free Cash Flow$ -10.50M$ -13.43M$ -13.37M$ -16.89M$ -25.42M
Operating Cash Flow$ -10.50M$ -13.43M$ -13.37M$ -16.57M$ -25.25M
Investing Cash Flow---$ -316.00K$ -170.00K
Financing Cash Flow$ 954.00K$ -1.63M$ -2.24M$ -992.00K$ -1.69M
Currency in USD

Xilio Therapeutics Earnings and Revenue History

Xilio Therapeutics Debt to Assets

Xilio Therapeutics Cash Flow

Xilio Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis